Integra Lifesciences Holdings (IART) Operating Margin (2016 - 2025)
Historic Operating Margin for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to 2.93%.
- Integra Lifesciences Holdings' Operating Margin rose 50700.0% to 2.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.26%, marking a year-over-year decrease of 311100.0%. This contributed to the annual value of 1.76% for FY2024, which is 54700.0% down from last year.
- Per Integra Lifesciences Holdings' latest filing, its Operating Margin stood at 2.93% for Q3 2025, which was up 50700.0% from 123.36% recorded in Q2 2025.
- In the past 5 years, Integra Lifesciences Holdings' Operating Margin registered a high of 17.04% during Q4 2022, and its lowest value of 123.36% during Q2 2025.
- Its 5-year average for Operating Margin is 1.19%, with a median of 8.53% in 2021.
- As far as peak fluctuations go, Integra Lifesciences Holdings' Operating Margin skyrocketed by 78500bps in 2021, and later tumbled by -1226300bps in 2025.
- Quarter analysis of 5 years shows Integra Lifesciences Holdings' Operating Margin stood at 14.36% in 2021, then grew by 19bps to 17.04% in 2022, then crashed by -47bps to 9.08% in 2023, then dropped by -11bps to 8.05% in 2024, then crashed by -64bps to 2.93% in 2025.
- Its last three reported values are 2.93% in Q3 2025, 123.36% for Q2 2025, and 4.05% during Q1 2025.